vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and WORLD ACCEPTANCE CORP (WRLD). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $141.3M, roughly 1.9× WORLD ACCEPTANCE CORP). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -0.6%, a 1.4% gap on every dollar of revenue. On growth, WORLD ACCEPTANCE CORP posted the faster year-over-year revenue change (1.9% vs -16.5%). WORLD ACCEPTANCE CORP produced more free cash flow last quarter ($57.2M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Credit Acceptance Corporation is an auto finance company providing automobile loans and other related financial products. The company operates its financial program through a national network of dealer-partners, the automobile dealers participating in the programs. The company operates two programs: the "Portfolio Program" and the "Purchase Program". Through these programs, the company can advance money to automobile dealers in exchange for the right to service the underlying consumer loans a...

HCM vs WRLD — Head-to-Head

Bigger by revenue
HCM
HCM
1.9× larger
HCM
$270.8M
$141.3M
WRLD
Growing faster (revenue YoY)
WRLD
WRLD
+18.4% gap
WRLD
1.9%
-16.5%
HCM
Higher net margin
HCM
HCM
1.4% more per $
HCM
0.7%
-0.6%
WRLD
More free cash flow
WRLD
WRLD
$53.8M more FCF
WRLD
$57.2M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HCM
HCM
WRLD
WRLD
Revenue
$270.8M
$141.3M
Net Profit
$2.0M
$-911.3K
Gross Margin
37.7%
Operating Margin
-13.2%
-0.7%
Net Margin
0.7%
-0.6%
Revenue YoY
-16.5%
1.9%
Net Profit YoY
-83.6%
-106.8%
EPS (diluted)
$0.00
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
WRLD
WRLD
Q4 25
$270.8M
$141.3M
Q3 25
$134.5M
Q2 25
$277.7M
$132.5M
Q1 25
$324.5M
$165.3M
Q4 24
$138.6M
Q3 24
$131.4M
Q2 24
$305.7M
$129.5M
Q1 24
$159.3M
Net Profit
HCM
HCM
WRLD
WRLD
Q4 25
$2.0M
$-911.3K
Q3 25
$-1.9M
Q2 25
$455.0M
$1.3M
Q1 25
$11.9M
$44.3M
Q4 24
$13.4M
Q3 24
$22.1M
Q2 24
$25.8M
$9.9M
Q1 24
$35.1M
Gross Margin
HCM
HCM
WRLD
WRLD
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
WRLD
WRLD
Q4 25
-13.2%
-0.7%
Q3 25
-1.3%
Q2 25
-1.3%
1.5%
Q1 25
-5.0%
33.3%
Q4 24
11.6%
Q3 24
21.3%
Q2 24
-9.0%
10.0%
Q1 24
29.3%
Net Margin
HCM
HCM
WRLD
WRLD
Q4 25
0.7%
-0.6%
Q3 25
-1.4%
Q2 25
163.8%
1.0%
Q1 25
3.7%
26.8%
Q4 24
9.7%
Q3 24
16.8%
Q2 24
8.4%
7.7%
Q1 24
22.0%
EPS (diluted)
HCM
HCM
WRLD
WRLD
Q4 25
$0.00
$-0.19
Q3 25
$-0.38
Q2 25
$0.52
$0.25
Q1 25
$0.01
$8.07
Q4 24
$2.45
Q3 24
$3.99
Q2 24
$0.03
$1.79
Q1 24
$6.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
WRLD
WRLD
Cash + ST InvestmentsLiquidity on hand
$1.4B
$10.0M
Total DebtLower is stronger
$93.2M
$677.2M
Stockholders' EquityBook value
$1.2B
$351.6M
Total Assets
$1.8B
$1.1B
Debt / EquityLower = less leverage
0.08×
1.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
WRLD
WRLD
Q4 25
$1.4B
$10.0M
Q3 25
$14.9M
Q2 25
$1.4B
$8.1M
Q1 25
$836.1M
$4.7M
Q4 24
$10.3M
Q3 24
$9.7M
Q2 24
$802.5M
$11.1M
Q1 24
$5.2M
Total Debt
HCM
HCM
WRLD
WRLD
Q4 25
$93.2M
$677.2M
Q3 25
$584.6M
Q2 25
$93.4M
$472.5M
Q1 25
$82.8M
$447.9M
Q4 24
$561.2M
Q3 24
$506.6M
Q2 24
$82.1M
$494.7M
Q1 24
$498.4M
Stockholders' Equity
HCM
HCM
WRLD
WRLD
Q4 25
$1.2B
$351.6M
Q3 25
$365.6M
Q2 25
$1.2B
$427.9M
Q1 25
$759.9M
$439.5M
Q4 24
$428.2M
Q3 24
$417.5M
Q2 24
$740.1M
$422.6M
Q1 24
$424.4M
Total Assets
HCM
HCM
WRLD
WRLD
Q4 25
$1.8B
$1.1B
Q3 25
$1.1B
Q2 25
$1.8B
$1.0B
Q1 25
$1.3B
$1.0B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.3B
$1.0B
Q1 24
$1.1B
Debt / Equity
HCM
HCM
WRLD
WRLD
Q4 25
0.08×
1.93×
Q3 25
1.60×
Q2 25
0.08×
1.10×
Q1 25
0.11×
1.02×
Q4 24
1.31×
Q3 24
1.21×
Q2 24
0.11×
1.17×
Q1 24
1.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
WRLD
WRLD
Operating Cash FlowLast quarter
$8.2M
$58.0M
Free Cash FlowOCF − Capex
$3.4M
$57.2M
FCF MarginFCF / Revenue
1.2%
40.5%
Capex IntensityCapex / Revenue
1.8%
0.6%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$412.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
WRLD
WRLD
Q4 25
$8.2M
$58.0M
Q3 25
$48.6M
Q2 25
$-72.9M
$58.2M
Q1 25
$40.3M
$254.2M
Q4 24
$61.1M
Q3 24
$53.8M
Q2 24
$-39.8M
$48.4M
Q1 24
$265.8M
Free Cash Flow
HCM
HCM
WRLD
WRLD
Q4 25
$3.4M
$57.2M
Q3 25
$47.7M
Q2 25
$-82.2M
$57.1M
Q1 25
$32.5M
$250.5M
Q4 24
$60.4M
Q3 24
$52.7M
Q2 24
$-49.9M
$47.3M
Q1 24
$259.9M
FCF Margin
HCM
HCM
WRLD
WRLD
Q4 25
1.2%
40.5%
Q3 25
35.5%
Q2 25
-29.6%
43.1%
Q1 25
10.0%
151.6%
Q4 24
43.6%
Q3 24
40.1%
Q2 24
-16.3%
36.5%
Q1 24
163.2%
Capex Intensity
HCM
HCM
WRLD
WRLD
Q4 25
1.8%
0.6%
Q3 25
0.7%
Q2 25
3.3%
0.8%
Q1 25
2.4%
2.2%
Q4 24
0.5%
Q3 24
0.8%
Q2 24
3.3%
0.8%
Q1 24
3.7%
Cash Conversion
HCM
HCM
WRLD
WRLD
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
43.27×
Q1 25
3.38×
5.74×
Q4 24
4.56×
Q3 24
2.43×
Q2 24
-1.54×
4.87×
Q1 24
7.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons